Shots:

• The collaboration leverages Luminostics’ technology and Sanofi’s global distribution network to ensure WW availability of the test- subject to relevant regulatory approvals. The focus of the collaboration is to develop a consumer-based test that can detect the COVID-19
• Luminostics’ technology utilizes a consumer smartphone’s optics- controlled by an iOS/Android app paired with a reusable adapter- in combination with glow-in-the-dark nanochemistry and signal processing AI. The OTC self-testing solution is expected to be ready before the end of 2020
• The rapid self-testing solution will eliminate the current need for HCPs or laboratory tests. The collaboration follows Sanofi’s collaboration with GSK for COVID-19 vaccine and initiation of clinical studies evaluating Kevzara and Plaquenil in patients suffering from COVID-19

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: Usine Digitale

Related News: Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19

Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US